文献速递焦虑、强迫与应激相关障碍心境障碍

创伤后应激障碍与心理弹性的分子及神经内分泌发现向新型治疗的转化

Translating Molecular and Neuroendocrine Findings in Posttraumatic Stress Disorder and Resilience to Novel Therapies.
PubMed 文献 · Biol Psychiatry · 2019-07-24

本文批判性综述了PTSD与心理弹性相关的神经生物学发现及由此衍生的药物治疗策略。涉及的药物靶点包括肾上腺素能系统、下丘脑-垂体-肾上腺轴和神经肽Y系统;氯胺酮和3,4-亚甲二氧基甲基苯丙胺辅助心理治疗也显示出前景,但其神经生物学机制尚未完全阐明。

要点

  • PTSD和弹性的神经生物学靶点包括肾上腺素能、HPA轴和神经肽Y系统。
  • 氯胺酮和MDMA辅助心理治疗是PTSD的新兴策略但机制未明。
  • 治疗研究中的神经生物学检查可能揭示新靶点并促进对康复机制的理解。

核心结论

  • PTSD的合理药物治疗直接靶向已知与创伤后症状相关的失调系统。
  • 氯胺酮和MDMA辅助心理治疗可能通过改变心理状态促进心理治疗参与。
  • 在治疗研究中开展神经生物学检查有助于发现新靶点和理解康复机制。

研究设计与样本

  • 本文为针对PTSD和心理弹性相关神经生物学发现及药物学方法的批判性综述。

主要发现

  • 多种生物系统与PTSD和心理弹性相关改变。
  • 针对肾上腺素能、HPA轴和神经肽Y系统的药物已被总结。
  • 氯胺酮和MDMA辅助心理治疗是PTSD的新兴策略,但其神经生物学机制尚未完全理解。

临床怎么用

  • 合理药物治疗可靶向肾上腺素能、HPA轴和神经肽Y系统等失调系统。
  • 氯胺酮和MDMA辅助心理治疗可用于PTSD症状改善和弹性促进。
  • 治疗研究中的神经生物学检查可帮助识别新靶点和康复机制。

局限性

  • 氯胺酮和MDMA辅助心理治疗的神经生物学机制尚未完全理解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many biological systems are altered in association with posttraumatic stress disorder (PTSD) and resilience. However, there are only few approved pharmacological treatments for PTSD, and no approved medications to enhance resilience. This article provides a critical review of select neurobiological findings in PTSD and resilience, and also of pharmacologic approaches that have emerged from this work. The medications summarized involve engagement with targets in the adrenergic, hypothalamic-pituitary-adrenal axis, and neuropeptide Y systems. Other highlighted approaches involve the use of ketamine and 3,4-methylenedioxymethamphetamine-assisted psychotherapy, which recently surfaced as promising strategies for PTSD, though the neurobiological mechanisms underlying their actions, including for promoting resilience, are not yet fully understood. The former approaches fall within the broad concept of "rational pharmacotherapy," in that they attempt to directly target dysregulated systems known to be associated with posttraumatic symptoms. To the extent that use of ketamine and 3,4-methylenedioxymethamphetamine promotes symptom improvement and resilience in PTSD, this provides an opportunity for reverse translation and identification of relevant targets and mechanisms of action through careful study of biological changes resulting from these interventions. Promoting resilience in trauma-exposed individuals may involve more than pharmacologically manipulating dysregulated molecules and pathways associated with developing and sustaining PTSD symptom severity, but also producing a substantial change in mental state that increases the ability to engage with traumatic material in psychotherapy. Neurobiological examination in the context of treatment studies may yield novel targets and promote a greater understanding of mechanisms of recovery from trauma.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. DePierro J, Lepow L, Feder A, et al. Translating Molecular and Neuroendocrine Findings in Posttraumatic Stress Disorder and Resilience to Novel Therapies. Biol Psychiatry. 2019. PMID: 31466562. doi:10.1016/j.biopsych.2019.07.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。